In this episode of #AskDrDurie, IMF Chairman and Co-Founder Dr. Brian G.M. Durie discusses the important factors one must consider when selecting individualized treatment for myeloma.

Dr. Brian G.M. Durie is the Chairman of the Board of Directors of the International Myeloma Foundation. He began studying multiple myeloma over 30 years ago, and is recognized around the world as one of the top myeloma doctors.

Previous Post
#AskDrDurie: Can a low white blood cell count be enough to trigger a need for myeloma therapy?
Next Post
#AskDrDurie: Are PET/CT scans useful for a patient with MGUS?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.